ReviewCardiovascular endocrinology & metabolism2020

The systemic implication of novel non-statin therapies in cardiovascular diabetology: PCSK9 as a case model.

Mouhamed Nashawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.